Editorial draft — not for publication yet. Nitrazepam content needs review by a qualified UK healthcare professional before publication. This page is general information and is not advice about an individual prescription.
In short
Nitrazepam is a long-acting prescription benzodiazepine hypnotic indicated in UK product information for short-term treatment of severe or disabling insomnia in adults. It can cause next-day drowsiness, impaired memory, coordination and driving, falls, and dangerous sedation with alcohol or opioids. Tolerance, dependence, addiction and withdrawal are possible; treatment should be brief and stopping should be planned with a prescriber.
What is Nitrazepam used for?
The UK Mogadon 5 mg tablet information indicates nitrazepam for short-term treatment of insomnia when it is severe, disabling or causing unacceptable distress, where daytime sedation is acceptable. A prescriber should consider the underlying cause before treatment.
- Short-term treatment of severe, disabling or very distressing insomnia in adults
- May shorten the time taken to fall asleep and lengthen sleep
- Not a general anxiety treatment, long-term insomnia solution or medicine for occasional poor sleep
The selected Mogadon product information describes a few days to two weeks in general and a maximum of four weeks including tapering. Treatment beyond this needs re-evaluation; long-term use is not recommended.
The MHRA strengthened benzodiazepine warnings in January 2026. Dependence, addiction, tolerance and withdrawal risks should be discussed before starting, with an individual strategy for ending treatment.
NHS guidance says persistent insomnia should be assessed for causes and may be treated with CBT. A sleeping medicine can relieve symptoms temporarily without curing the underlying cause.
How does it work?
Nitrazepam is a benzodiazepine that acts on calming signals in the central nervous system, producing sedative and hypnotic effects. It can help shorten the time to fall asleep and lengthen sleep, but it is long-acting and may impair alertness, memory, coordination and driving the next day.
How to take Nitrazepam
- Follow the exact instructions on your prescription label and patient leaflet. Products and formulations can have different strengths and directions; your prescriber must select your dose.
- Take it only as prescribed, immediately before bed, and allow the uninterrupted sleep period stated in your own leaflet.
- Do not take an extra dose, increase the amount, share tablets or combine nitrazepam with alcohol or another sedative.
- Do not drive or operate machinery if you feel sleepy, dizzy, confused or impaired. Nitrazepam can affect driving into the next day.
- Agree the length of treatment and a stopping plan with the prescriber before starting. Do not stop regular use suddenly without medical advice.
Important: Use the instructions on your own prescription or medicine label. Doses and directions can differ between people and products.
Side effects
Common effects
The selected Mogadon SmPC lists drowsiness, reduced alertness, headache and dizziness as common. Muscle weakness, fatigue, ataxia, double vision and confusion may also occur.
Get urgent help
Call 999 for severe breathing difficulty, collapse, seizure, inability to wake or another life-threatening reaction. Contact a clinician promptly for severe confusion, hallucinations, falls or major mood or behavioural changes.
Warnings and interactions
- The selected Mogadon information lists severe respiratory insufficiency, sleep apnoea syndrome, myasthenia gravis and severe hepatic insufficiency among contraindications. A prescriber must check the exact product and your health.
- Nitrazepam is long-acting and can impair memory, coordination and driving. Older adults may be more sensitive and have an increased falls risk.
- Avoid alcohol. Combining nitrazepam with opioids, other benzodiazepines or sedatives can cause profound sedation, respiratory depression, coma and death.
- The MHRA warns that benzodiazepines can cause tolerance, dependence, addiction and withdrawal, including when used as directed. Discuss how to stop before treatment begins.
- Tell your prescriber about pregnancy, breastfeeding, mental-health conditions, lung or liver problems, falls, alcohol use and every medicine or supplement you take.
Nitrazepam is a Class C controlled drug and is listed in Schedule 4 Part I of the Misuse of Drugs Regulations 2001. Use only medicine prescribed for you; this summary is not legal advice.
Short-term treatment and the reason for insomnia
Nitrazepam is indicated for severe short-term insomnia, not as a general treatment for anxiety or everyday stress. The product information says an underlying cause should be sought. Pain, anxiety, depression, sleep apnoea, alcohol, caffeine and other medicines may all affect sleep.
For the selected tablet, the product information describes a few days to two weeks in general and a maximum of four weeks including tapering unless a clinician re-evaluates the patient. If insomnia continues, ask a GP about assessment and options such as CBT rather than extending the course yourself.
Long-acting effects and driving
The Mogadon SmPC reports an average plasma half-life of about 30 hours. This does not mean a person feels equally sedated throughout that time, but next-day drowsiness, slower reactions, poor coordination and impaired memory can occur. Do not drive until you know how the medicine affects you, and never drive if impaired.
Alcohol, opioids and other sedatives can increase impairment and breathing-related risk. Avoid these combinations and ask a pharmacist to review your full medicines list.
Dependence and stopping safely
The MHRA strengthened benzodiazepine warnings in January 2026. Tolerance, dependence, addiction and withdrawal can occur, even at prescribed doses. Before starting, discuss how long treatment is expected to last and how it will end.
Do not stop regular nitrazepam suddenly. A prescriber can tailor a gradual reduction plan; after prolonged use this may take weeks or months.
Nitrazepam is not a general anxiety medicine
Nitrazepam is indicated for severe short-term insomnia. Sedation may temporarily make someone feel calmer, but it does not assess or treat the underlying cause of anxiety and carries dependence and impairment risks.
If anxiety is keeping you awake, tell a GP about both the anxiety and sleep problem. They can assess possible causes and discuss appropriate support. Do not use someone else’s medicine or take a higher dose.
Frequently asked questions
What is nitrazepam prescribed for?
UK product information indicates nitrazepam for short-term treatment of severe or disabling insomnia in adults.
How long can nitrazepam be taken?
For the selected Mogadon tablet, treatment is generally described as a few days to two weeks, with a maximum of four weeks including tapering unless a prescriber re-evaluates the patient.
Can nitrazepam affect driving the next day?
Yes. Nitrazepam is long-acting and may impair alertness, memory and coordination after waking. Do not drive if affected.
Can nitrazepam cause withdrawal?
Yes. Dependence and withdrawal can occur. Speak with your prescriber before stopping regular use; do not stop suddenly.
Explore the detailed nitrazepam guides
Each guide answers a different practical question. Advice is specific to nitrazepam and should be checked against your own product leaflet and prescription.
- What is nitrazepam used for? UK insomnia guidance
- Nitrazepam for insomnia: short-term use and safer next steps
- How does nitrazepam work? Sleep effects explained
- Nitrazepam dosage: how to take it safely
- How long does nitrazepam take to work and last?
- Nitrazepam side effects: drowsiness, memory and falls
- Serious nitrazepam side effects and urgent help
- Nitrazepam warnings: who may not be able to take it?
- Nitrazepam interactions with opioids and other medicines
- Can you drink alcohol with nitrazepam?
- Nitrazepam in pregnancy and breastfeeding: UK advice
- Can you drive after taking nitrazepam?
- Nitrazepam dependence and withdrawal: stopping safely
- Missed nitrazepam dose or overdose: what to do
- Nitrazepam alternatives for insomnia: CBT and treatment options
- Nitrazepam for anxiety? UK use and safer next steps
- Nitrazepam vs zopiclone: UK guidance and differences
- Is nitrazepam legal in the UK? Prescription and controlled status
Sources and review
This draft was checked against the sources below on 2 October 2026. It still requires review by a qualified UK healthcare professional review before publication.
- electronic Medicines Compendium: Mogadon 5 mg tablets: Summary of Product Characteristics
- electronic Medicines Compendium: Mogadon 5 mg tablets: Patient Information Leaflet
- electronic Medicines Compendium: Nitrazepam 2.5 mg/5 ml oral solution: Summary of Product Characteristics
- electronic Medicines Compendium: Nitrazepam 2.5 mg/5 ml oral solution: Patient Information Leaflet
- NHS: Insomnia: NHS causes, self-care and treatment information
- NICE: NICE TA77: short-term management of insomnia
- MHRA / GOV.UK: MHRA: strengthened benzodiazepine and Z-drug dependence warnings
- MHRA: Benzodiazepines: addiction, dependence and withdrawal (patient resource)
- legislation.gov.uk: Misuse of Drugs Regulations 2001: Schedule 4
- GOV.UK: Drugs and driving: the law
- NHS: Poisoning: what to do in an emergency
Editorial status: Clinical review required before publication.